REFERENCES
1. WHO. Breast cancer. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer [Last accessed on 27 Dec 2023].
2. Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95:20211033.
3. Khan SA, Zhao F, Goldstein LJ, et al. Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (E2108). J Clin Oncol. 2022;40:978-87.
4. Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112:2577-92.
5. Ferrell BR, Grant M, Funk B, Otis-Green S, Garcia N. Quality of life in breast cancer. Part I: physical and social well-being. Cancer Nurs. 1997;20:398-408.
6. Hurvitz SA, Lalla D, Crosby RD, Mathias SD. Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer. Breast Cancer Res Treat. 2013;142:603-9.
7. Sales CACC, Paiva L, Scandiuzzi D, Anjos CAY. Qualidade de vida de mulheres tratadas de câncer de mama: funcionamento social. Rev Bras Cancerol. 2001;47:263-72.
8. Jiang Z, Li J, Chen J, et al. Chinese society of clinical oncology (CSCO) breast cancer guidelines 2022. Transl Breast Cancer Res. 2022;3:13.
9. NBCF. Stage 4 (IV) breast cancer. Available from: https://www.nationalbreastcancer.org/breast-cancer-stage-4/#:~:text=Although%20Stage%204%20breast%20cancer,life%20as%20a%20primary%20goal [Last accessed on 22 Dec 2023].
10. Carlson RW, Allred DC, Anderson BO, et al. Invasive breast cancer. J Natl Compr Canc Netw. 2011;9:136-222.
11. Gnerlich J, Dueker JM, Jeffe DB, Deshpande AD, Thompson S, Margenthaler JA. Patient and tumor characteristics associated with primary tumor resection in women with Stage IV breast cancer: analysis of 1988-2003 SEER data. Breast J. 2008;14:538-42.
12. Asaad M, Yonkus JA, Hoskin TL, et al. Primary tumor resection in patients with stage IV breast cancer: 10-year experience. Breast J. 2021;27:863-71.
13. Shien T, Iwata H. Significance of primary lesion resection in Stage IV breast cancer. Jpn J Clin Oncol. 2017;47:381-4.
14. Marks CE, Thomas SM, Fayanju OM, et al. Metastatic breast cancer: who benefits from surgery? Am J Surg. 2022;223:81-93.
15. Lane WO, Thomas SM, Blitzblau RC, et al. Surgical resection of the primary tumor in women with de novo stage IV breast cancer: contemporary practice patterns and survival analysis. Ann Surg. 2019;269:537-44.
16. Hotton J, Lusque A, Leufflen L, et al. Early locoregional breast surgery and survival in de novo metastatic breast cancer in the multicenter national ESME Cohort. Ann Surg. 2023;277:e153-61.
17. Tosello G, Torloni MR, Mota BS, Neeman T, Riera R. Breast surgery for metastatic breast cancer. Cochrane Database Syst Rev. 2018;3:CD011276.
18. Arciero C, Liu Y, Gillespie T, Subhedar P. Surgery and survival in patients with stage IV breast cancer. Breast J. 2019;25:644-53.
19. Soran A, Ozmen V, Ozbas S, et al. A randomized controlled trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer: Turkish study (protocol MF07-01). J Clin Oncol. 2016;34:1005.
20. Baum M, Demicheli R, Hrushesky W, Retsky M. Does surgery unfavourably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer. 2005;41:508-15.
21. Coffey JC, Wang JH, Smith MJ, Bouchier-Hayes D, Cotter TG, Redmond HP. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol. 2003;4:760-8.
22. Patel F, Sharma SC. Non-surgical management of metastatic breast cancer and palliative care. In Sharma SC, Mazumdar A,
23. Zafir-Lavie I, Sherbo S, Goltsman H, et al. Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases. J Control Release. 2018;291:80-9.
24. Ye F, Dewanjee S, Li Y, et al. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer. 2023;22:105.
25. Fallowfield L, Boyle FM, Travado L, et al. Gaps in care and support for patients with advanced breast cancer: a report from the advanced breast cancer global alliance. JCO Glob Oncol. 2021;7:976-84.
26. Page MJ, Moher D, McKenzie JE. Introduction to preferred reporting items for systematic reviews and meta-analyses 2020 and implications for research synthesis methodologists. Res Synth Methods. 2022;13:156-63.
27. Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12:9.
28. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
29. Badwe R, Hawaldar R, Nair N, et al. Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. Lancet Oncol. 2015;16:1380-8.
30. Fitzal F, Bjelic-Radisic V, Knauer M, et al. Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase III ABCSG-28 posytive trial. Ann Surg. 2019;269:1163-9.
31. Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01. Ann Surg Oncol. 2018;25:3141-9.
32. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132:620-6; discussion 626-7.
33. Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol. 2006;24:2743-9.
34. Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006;13:776-82.
35. Fields RC, Jeffe DB, Trinkaus K, et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol. 2007;14:3345-51.
36. Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg. 2008;247:732-8.
37. Cady B, Nathan NR, Michaelson JS, Golshan M, Smith BL. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Ann Surg Oncol. 2008;15:3384-95.
38. Hazard HW, Gorla SR, Scholtens D, Kiel K, Gradishar WJ, Khan SA. Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer. Cancer. 2008;113:2011-9.
39. Ahn S, Han W, Min J, et al. Impact of primary site surgical resection on survival in stage IV breast Cancer. Cancer Res. 2010;13:90-5.
40. McGuire KP, Eisen S, Rodriguez A, Meade T, Cox CE, Khakpour N. Factors associated with improved outcome after surgery in metastatic breast cancer patients. Am J Surg. 2009;198:511-5.
41. Ruiterkamp J, Ernst MF, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol. 2009;35:1146-51.
42. Shien T, Kinoshita T, Shimizu C, et al. Primary tumor resection improves the survival of younger patients with metastatic breast cancer. Oncol Rep. 2009;21:827-32.
43. Leung AM, Vu HN, Nguyen KA, Thacker LR, Bear HD. Effects of surgical excision on survival of patients with stage IV breast cancer. J Surg Res. 2010;161:83-8.
44. Neuman HB, Morrogh M, Gonen M, Van Zee KJ, Morrow M, King TA. Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer. 2010;116:1226-33.
45. Pathy NB, Verkooijen HM, Taib NA, Hartman M, Yip CH. Impact of breast surgery on survival in women presenting with metastatic breast cancer. Br J Surg. 2011;98:1566-72.
46. Pérez-Fidalgo JA, Pimentel P, Caballero A, et al. Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes? Breast. 2011;20:548-54.
47. Rashaan ZM, Bastiaannet E, Portielje JE, et al. Surgery in metastatic breast cancer: patients with a favorable profile seem to have the most benefit from surgery. Eur J Surg Oncol. 2012;38:52-6.
48. Lang JE, Tereffe W, Mitchell MP, et al. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol. 2013;20:1893-9.
49. Akay CL, Ueno NT, Chisholm GB, et al. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer. 2014;120:1319-28.
50. Anula JJ, Sánchez Andújar B, Machuca Chiriboga P, Navarro Cecilia J, Dueñas Rodríguez B. Tratamiento quirúrgico del tumor primario en pacientes con cáncer de mama en estadio IV. [Surgical treatment of the primary tumor in stage IV breast cancer]. Cir Esp. 2015;93:375-80.
51. Rhu J, Lee SK, Kil WH, Lee JE, Nam SJ. Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone. ANZ J Surg. 2015;85:240-4.
52. Quinn EM, Kealy R, O’Meara S, et al. Is there a role for locoregional surgery in stage IV breast cancer? Breast. 2015;24:32-7.
53. Thomas A, Khan SA, Chrischilles EA, Schroeder MC. Initial surgery and survival in stage IV breast cancer in the United States, 1988-2011. JAMA Surg. 2016;151:424-31.
54. Kolben T, Kolben TM, Himsl I, et al. Local resection of primary tumor in upfront stage IV breast cancer. Breast Care. 2016;11:411-7.
55. Xie Y, Lv X, Luo C, et al. Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China: a retrospective analysis. Medicine. 2017;96:e7048.
56. Muzaffar M, Kachare S, Vohra N. Impact of primary tumor surgery in stage IV male breast cancer. Clin Breast Cancer. 2017;17:e143-9.
57. Yoo TK, Chae BJ, Kim SJ, et al. Identifying long-term survivors among metastatic breast cancer patients undergoing primary tumor surgery. Breast Cancer Res Treat. 2017;165:109-18.
58. Barinoff J, Schmidt M, Schneeweiss A, et al. Primary metastatic breast cancer in the era of targeted therapy - prognostic impact and the role of breast tumour surgery. Eur J Cancer. 2017;83:116-24.
59. Choi SH, Kim JW, Choi J, et al. Locoregional treatment of the primary tumor in patients with de novo stage IV breast cancer: a radiation oncologist’s perspective. Clin Breast Cancer. 2018;18:e167-78.
60. Desille-Gbaguidi H, Avigdor S, Body G, Ouldamer L. Survival impact of primary site surgery on metastatic breast cancer patients at diagnosis. J Gynecol Obstet Hum Reprod. 2019;48:171-7.
61. Lim SM, Kim JY, Park HS, et al. Effect of primary tumor resection on overall survival in patients with stage IV breast cancer. Breast J. 2019;25:908-15.
62. Lopez-Tarruella S, Escudero MJ, Pollan M, et al. Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry). Sci Rep. 2019;9:20081.
63. Wang K, Shi Y, Li ZY, et al. Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: a real-world observational study. Eur J Surg Oncol. 2019;45:1364-72.
64. Mudgway R, Chavez de Paz Villanueva C, Lin AC, Senthil M, Garberoglio CA, Lum SS. The impact of primary tumor surgery on survival in HER2 positive stage IV breast cancer patients in the current era of targeted therapy. Ann Surg Oncol. 2020;27:2711-20.
65. Si Y, Yuan P, Hu N, et al. Primary tumor surgery for patients with de novo stage IV breast cancer can decrease local symptoms and improve quality of life. Ann Surg Oncol. 2020;27:1025-33.
66. Yao N, Li W, Liu T, et al. Primary tumor removal improves the prognosis in patients with stage IV breast cancer: a population-based study (cohort study). Int J Surg. 2020;83:109-14.
67. Bilani N, Elson L, Liang H, Elimimian EB, Nahleh Z. Effect of surgery at primary and metastatic sites in patients with stage IV breast cancer. Clin Breast Cancer. 2021;21:170-80.
68. Bilani N, Yaghi M, Singh Jabbal I, et al. Survival benefit of a combined surgical approach in patients with metastatic breast cancer. J Surg Oncol. 2021;124:1235-41.
69. Çöpelci Y, Gündüz UR, Dinç B, Belen NH, Gündüz Ş. Effects of primary tumor resection on metastatic breast cancer survival and the predictive power of neutrophil: lymphocyte ratio on prognosis. Eur J Breast Health. 2021;17:322-7.
70. Huang Z, Tan Q, Qin Q, Mo Q, Wei C. Impact of primary site surgery on survival of patients with de novo stage IV breast cancer. Cancer Manag Res. 2021;13:319-27.
71. Xie N, Hu X, Tang Y, et al. Impact of surgical management of primary tumors in stage IV breast cancer patients: a retrospective observational study based on SEER database. BMJ Open. 2022;12:e054135.
72. Dominici L, Najita J, Hughes M, et al. Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast Cancer Res Treat. 2011;129:459-65.
73. Wang W, Wang X, Liu J, Gao J, Zhang P, Zhao D. 130P locoregional treatment in de novo stage IV breast cancer: a retrospective study of the Chinese population. Ann Oncol. 2016;27:ix39.
74. Kim MY, Oskarsson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells. Cell. 2009;139:1315-26.
75. Petrelli F, Barni S. Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression. Med Oncol. 2012;29:3282-90.
76. Harris E, Barry M, Kell MR. Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival. Ann Surg Oncol. 2013;20:2828-34.
77. Xiao W, Zou Y, Zheng S, et al. Primary tumor resection in stage IV breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2018;44:1504-12.
78. Mohanty SS, Sahoo CR, Padhy RN. Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: an update. Genes Dis. 2022;9:648-58.
79. Winokur T. Molecular markers in breast cancer: current practice and future possibilities. Springer Science & Business Media. 2007. Available from: https://link.springer.com/chapter/10.1007/0-387-32025-3_5 [Last accessed on 27 Dec 2023].
80. Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. Oncologist. 2004;9:606-16.
81. Saez RA, McGuire WL, Clark GM. Prognostic factors in breast cancer. Semin Surg Oncol. 1989;5:102-10.
